E-viri
PDF
Recenzirano
Odprti dostop
-
Gladman, Dafna; Rigby, William; Azevedo, Valderilio F; Behrens, Frank; Blanco, Ricardo; Kaszuba, Andrzej; Kudlacz, Elizabeth; Wang, Cunshan; Menon, Sujatha; Hendrikx, Thijs; Kanik, Keith S
The New England journal of medicine, 10/2017, Letnik: 377, Številka: 16Journal Article
Treatment of psoriatic arthritis with the oral Janus kinase inhibitor tofacitinib for 3 months was more effective than placebo in reducing joint manifestations, as determined by the American College of Rheumatology 20% response rate, but was associated with herpes infections.
